- Patent Title: Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
-
Application No.: US15892356Application Date: 2018-02-08
-
Publication No.: US10682406B2Publication Date: 2020-06-16
- Inventor: Andreas Thess , Thomas Schlake , Jochen Probst
- Applicant: CureVac AG
- Applicant Address: DE Tübingen
- Assignee: CureVac AG
- Current Assignee: CureVac AG
- Current Assignee Address: DE Tübingen
- Agency: Parker Highlander PLLC
- Main IPC: A61K39/145
- IPC: A61K39/145 ; C12N15/67 ; A61K39/00 ; C12N15/63 ; A61K39/12 ; C12N7/00

Abstract:
The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a pathogenic antigen or a fragment, variant or derivative thereof, at least one histone stem-loop and a poly(A) sequence or a polyadenylation signal. Furthermore the present invention provides the use of the nucleic acid for increasing the expression of said encoded peptide or protein. It also discloses its use for the preparation of a pharmaceutical composition, especially a vaccine, e.g. for use in the treatment of infectious diseases. The present invention further describes a method for increasing the expression of a peptide or protein comprising a pathogenic antigen or a fragment, variant or derivative thereof, using the nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal.
Public/Granted literature
Information query